<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>388(6)</volume><submitter>Wang Q</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>the NIH SARS-CoV-2 Assessment of Viral Evolution (SAVE) Program</funding><funding>NIAID NIH HHS</funding><journal>The New England journal of medicine</journal><pagination>567-569</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9847504</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Antibody Response to Omicron BA.4-BA.5 Bivalent Booster.</pubmed_title><pmcid>PMC9847504</pmcid><funding_grant_id>75N93019C00051</funding_grant_id><funding_grant_id>T32 AI100852</funding_grant_id><funding_grant_id>UM1 AI069470</funding_grant_id><pubmed_authors>Ho DD</pubmed_authors><pubmed_authors>Gherasim C</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Liu L</pubmed_authors><pubmed_authors>Bowen A</pubmed_authors><pubmed_authors>Valdez R</pubmed_authors><pubmed_authors>Gordon A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antibody Response to Omicron BA.4-BA.5 Bivalent Booster.</name><description/><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-06T08:48:12.188Z</modification><creation>2025-02-19T01:08:16.964Z</creation></dates><accession>S-EPMC9847504</accession><cross_references><pubmed>36630643</pubmed><doi>10.1056/NEJMc2213907</doi></cross_references></HashMap>